Skip to content

Comparing suture thread and skin staplers for skin closure after cesarean delivery

Comparison between polyglecaparone 25 suture versus skin stapler for skin closure in Cesarean delivery - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097038
Enrollment
66
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z481- Encounter for planned postprocedural wound closure

Interventions

Intervention1: Skin stapler: Skin closure using disposable sterile stainless steel skin stapler (Surgipler Neo) applied as per manufacturers instructions. Control Intervention1: Poliglecaprone-25 sutu
no external sutures.

Sponsors

Adichunchanagiri Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women aged 18–45 years undergoing LSCS (elective or emergency) Skin closure planned with single layer subcuticular technique Able and willing to provide written informed consent and attend follow-up visits

Exclusion criteria

Exclusion criteria: Known allergy to suture or staple material Current systemic infection or immunosuppression (e.g., long-term steroids, chemotherapy) Known bleeding disorder Significant obesity where fascial closure or wound management is expected to differ (BMI greater than 40 kg/m²) Multi-layer disrupted closure or major intraoperative complication requiring re-exploration Previous lower abdominal surgery with distorted anatomy at incision site

Design outcomes

Primary

MeasureTime frame
Incidence of surgical site infection (SSI), defined according to standard criteria (purulent drainage from incision, culture positive wound drainage, or physician diagnosis of superficial/deep incisional SSI requiring antibiotics or wound opening)Timepoint: Incidence of SSI within 30 days post operation.

Secondary

MeasureTime frame
Cosmetic outcome of the scar measured by a validated scale — e.g., Patient and Observer Scar Assessment Scale (POSAS)Timepoint: Day of discharge, 30 days post operation and 3 months post operation;Wound-related complications: seroma, hematoma, wound dehiscence/separation (partial/full), suture extrusion, hypertrophic scar/keloid formationTimepoint: Within 3 months of post operation;Postoperative pain at incision site (measured by Visual Analogue Scale)Timepoint: 24 hours post operation, 7 days post operation and 30 days post operation;Time taken for skin closure during Cesarean sectionTimepoint: Day of surgery;Re-admission related to wound complicationsTimepoint: within 30 days post operation;Patient satisfaction with wound healing (Likert scale)Timepoint: 3 months post operatively

Countries

India

Contacts

Public ContactMahendra G

Adichunchanagiri Institute of Medical Sciences

drmuba@gmail.com9964026610

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026